Insider · CIK 0001543031

Quimi Daphne

Reports to the SEC for 3 companies · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001543031

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+74K sh	—	—	74,000
2026-06-04	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.4K sh	—	—	24,372
2025-06-12	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2025-06-05	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-09-12	IPSCCentury Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.53	+$7,657	5,000
2024-06-20	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2024-06-06	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-05-15	AMLXAmylyx Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,250 sh	$1.89	+$4,252.275	5,000
2024-05-14	AMLXAmylyx Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,750 sh	$1.89	+$5,183.75	2,750
2023-06-27	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2023-06-08	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	16,985
2023-01-18	AMICUS THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−6,923 sh	$13.00	−$90K	398,532
2023-01-17	AMICUS THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−5,000 sh	$12.49	−$62.4K	405,455
2023-01-11	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+58.8K sh	—	—	440,020
2023-01-11	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−29.6K sh	$12.02	−$355K	410,455
2023-01-04	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−3,884 sh	$12.03	−$46.7K	381,196
2023-01-03	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+73.5K sh	—	—	393,655
2023-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−8,575 sh	$11.93	−$102K	385,080
2023-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+130K sh	—	—	130,480
2023-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−15.2K sh	$12.21	−$185K	320,147
2022-10-01	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.7K sh	—	—	39,744
2022-09-01	AMICUS THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−4,397 sh	$11.29	−$49.6K	335,312
2022-08-05	AMICUS THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−5,798 sh	$12.00	−$69.6K	339,709
2022-06-17	AMICUS THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−4,396 sh	$9.00	−$39.6K	345,507
2022-06-09	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2022-01-14	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+36.8K sh	—	—	368,746
2022-01-14	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−18.8K sh	$10.53	−$198K	349,903
2022-01-06	AMLXAmylyx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,400 sh	—	—	8,400
2022-01-04	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−4,041 sh	$12.48	−$50.4K	331,906
2022-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,538 sh	$12.11	−$18.6K	262,811
2022-01-03	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+73.1K sh	—	—	335,947
2022-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+134K sh	—	—	134,044
2022-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−15.8K sh	$11.55	−$182K	264,349
2021-12-31	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−10.5K sh	$11.55	−$121K	280,127
2021-04-06	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+19.3K sh	—	—	290,629
2021-03-05	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+16.6K sh	$2.94	+$48.9K	275,998
2021-03-05	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−4,664 sh	$10.48	−$48.9K	271,334
2021-03-05	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−16.6K sh	—	—	0
2021-01-15	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+9,502 sh	—	—	264,140
2021-01-15	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−4,770 sh	$21.84	−$104K	259,370
2021-01-04	AMICUS THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+33.1K sh	—	—	254,638
2021-01-04	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+53.4K sh	—	—	53,355
2021-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,053 sh	$23.09	−$117K	221,507
2021-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−15.2K sh	$23.09	−$350K	226,560
2020-12-31	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,620 sh	$23.09	−$60.5K	241,724
2020-12-21	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$2.94	+$14.7K	249,344
2020-12-21	AMICUS THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−5,000 sh	$24.09	−$120K	244,344
2020-12-21	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	16,628
2020-12-15	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.5K sh	$2.94	+$33.8K	229,679
2020-12-15	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,550 sh	$4.38	+$33.1K	237,229

Recent filings

Accepted (ET)
Jun 124
Quimi Daphne0001543031-26-000002
SEC(opens sec.gov)
Jun 84
Quimi Daphne0001193125-26-261640
SEC(opens sec.gov)
Jun 164
Quimi Daphne0001062993-25-011784
SEC(opens sec.gov)
Jun 94
Quimi Daphne0000950170-25-083717
SEC(opens sec.gov)
Sep 164
Quimi Daphne0001062993-24-016641
SEC(opens sec.gov)
Jun 214
Quimi Daphne0001062993-24-012905
SEC(opens sec.gov)
Jun 74
Quimi Daphne0000950170-24-070769
SEC(opens sec.gov)
May 164
Quimi Daphne0000950170-24-061294
SEC(opens sec.gov)
Jun 294
Quimi Daphne0001062993-23-014166
SEC(opens sec.gov)
Jun 124
Quimi Daphne0000899243-23-015408
SEC(opens sec.gov)
Jan 194
Quimi Daphne0001209191-23-004080
SEC(opens sec.gov)
Jan 134
Quimi Daphne0001209191-23-003306
SEC(opens sec.gov)
Jan 64
Quimi Daphne0001209191-23-002400
SEC(opens sec.gov)
Jan 44
Quimi Daphne0001209191-23-001394
SEC(opens sec.gov)

Companies

Address

C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR

PHILADELPHIA, PA, 19104